These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10415573)

  • 1. Factors in xenograft rejection.
    Robson SC; Schulte am Esch J; Bach FH
    Ann N Y Acad Sci; 1999 Jun; 875():261-76. PubMed ID: 10415573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular incompatibilities in hemostasis between swine and men--impact on xenografting.
    Schulte am Esch J; Rogiers X; Robson SC
    Ann Transplant; 2001; 6(3):12-6. PubMed ID: 11899892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed xenograft rejection.
    Hancock WW
    World J Surg; 1997; 21(9):917-23. PubMed ID: 9361505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of porcine endothelial tissue factor pathway inhibitor on human coagulation factors.
    Kopp CW; Siegel JB; Hancock WW; Anrather J; Winkler H; Geczy CL; Kaczmarek E; Bach FH; Robson SC
    Transplantation; 1997 Mar; 63(5):749-58. PubMed ID: 9075849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on coagulation incompatibilities for xenotransplantation.
    Bulato C; Radu C; Simioni P
    Methods Mol Biol; 2012; 885():71-89. PubMed ID: 22565991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human thrombin and FXa mediate porcine endothelial cell activation; modulation by expression of TFPI-CD4 and hirudin-CD4 fusion proteins.
    Chen D; Riesbeck K; McVey JH; Kemball-Cook G; Tuddenham EG; Lechler RI; Dorling A
    Xenotransplantation; 2001 Nov; 8(4):258-65. PubMed ID: 11737851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial induction of fgl2 contributes to thrombosis during acute vascular xenograft rejection.
    Ghanekar A; Mendicino M; Liu H; He W; Liu M; Zhong R; Phillips MJ; Levy GA; Grant DR
    J Immunol; 2004 May; 172(9):5693-701. PubMed ID: 15100314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of von Willebrand diseased kidney as donor in a pig-to-primate model of xenotransplantation.
    Meyer C; Wolf P; Romain N; Ravanat C; Roussi J; Beller JP; Imbs P; Chenard MP; Fabre M; Kieny R; Bonneau M; Drouet L; Cazenave JP; Soulillou JP; Azimzadeh A
    Transplantation; 1999 Jan; 67(1):38-45. PubMed ID: 9921793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute vascular rejection of xenografts: roles of natural and elicited xenoreactive antibodies in activation of vascular endothelial cells and induction of procoagulant activity.
    Gollackner B; Goh SK; Qawi I; Buhler L; Knosalla C; Daniel S; Kaczmarek E; Awwad M; Cooper DK; Robson SC
    Transplantation; 2004 Jun; 77(11):1735-41. PubMed ID: 15201675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of delayed rejection in transgenic pig-to-primate cardiac xenotransplantation.
    Chen RH; Kadner A; Mitchell RN; Adams DH
    J Surg Res; 2000 May; 90(2):119-25. PubMed ID: 10792951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coagulation dysregulation as a barrier to xenotransplantation in the primate.
    Lin CC; Cooper DK; Dorling A
    Transpl Immunol; 2009 Jun; 21(2):75-80. PubMed ID: 19000927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. O-linked glycosylation and functional incompatibility of porcine von Willebrand factor for human platelet GPIb receptors.
    Schulte Am Esch J; Robson SC; Knoefel WT; Hosch SB; Rogiers X
    Xenotransplantation; 2005 Jan; 12(1):30-7. PubMed ID: 15598271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A perspective on xenograft rejection and accommodation.
    Platt JL
    Immunol Rev; 1994 Oct; 141():127-49. PubMed ID: 7868152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic engineering as an approach to xenotransplantation.
    Bach FH
    World J Surg; 1997; 21(9):913-6. PubMed ID: 9361504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukocyte endothelial cell interactions in pig to human organ xenograft rejection.
    Holgersson J; Ehrnfelt C; Hauzenberger E; Serrander L
    Vet Immunol Immunopathol; 2002 Sep; 87(3-4):407-15. PubMed ID: 12072266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aurintricarboxylic acid inhibits endothelial activation, complement activation, and von Willebrand factor secretion in vitro and attenuates hyperacute rejection in an ex vivo model of pig-to-human pulmonary xenotransplantation.
    Kim HK; Kim JE; Wi HC; Lee SW; Kim JY; Kang HJ; Kim YT
    Xenotransplantation; 2008; 15(4):246-56. PubMed ID: 18957047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of complement-mediated activation of xenogeneic endothelial cells in an in vitro model of xenograft hyperacute rejection by C1 inhibitor.
    Dalmasso AP; Platt JL
    Transplantation; 1993 Nov; 56(5):1171-6. PubMed ID: 8249120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apyrase administration prolongs discordant xenograft survival.
    Koyamada N; Miyatake T; Candinas D; Hechenleitner P; Siegel J; Hancock WW; Bach FH; Robson SC
    Transplantation; 1996 Dec; 62(12):1739-43. PubMed ID: 8990354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis and pathology of delayed xenograft rejection in pig-to-rhesus monkey cardiac transplantation.
    Chen D; Cao R; Guo H; Chen G; Wang X; Shen S; Chen S
    Transplant Proc; 2004 Oct; 36(8):2480-2. PubMed ID: 15561288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial cell protection and complement inhibition in xenotransplantation: a novel in vitro model using whole blood.
    Banz Y; Cung T; Korchagina EY; Bovin NV; Haeberli A; Rieben R
    Xenotransplantation; 2005 Nov; 12(6):434-43. PubMed ID: 16202066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.